France Molecular Diagnostic Analyzers and Reagents Market 2021: Supplier Shares by Test, Competitive Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

June 2017 | 1125 pages | ID: FABABE6131CEN
Venture Planning Group

Abstracts

This new 1,125- page report from VPGMarketResearch.com contains 58 tables, and presents comprehensive analysis of the French molecular diagnostics market, including:

• Major issues pertaining to the French molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
• An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
• Ten- year test volume and reagent sales forecasts for the following categories:
• Infectious Diseases
• Genetic Diseases
• Cancer
• Paternity Testing/HLA Typing
• Forensic Testing
• Review of testing methodologies an instrumentation technologies.
• Feature comparison of automated and semiautomated analyzers.
• Sales and market shares of leading suppliers.
• Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
• Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know- how, new products in R&D, collaborative arrangements and business strategies.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.
• Business planning issues and concerns.

Contains 1,125 pages and 58 tables

Contents

I. INTRODUCTION

II. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products

III. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies For Decentralized Testing Markets

V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge And Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Worldwide Market and Technology Review
A. DNA Sequencing
  1. INTRODUCTION
  2. Sequencing Methods
  3. Autoradiography
  4. The Human Genome Project
  5. Sequencing Automation
  6. Image Scanners
  7. Fluorescent Detection
  8. Gene Profiling
  9. Gene Expression
  10. Polymorphism Screening
  11. Protein Interaction Networks
B. DNA and RNA Probe Technologies
  1. Basic Principles
  2. Probe Preparation
  3. The DNA Probe Test
  4. Test Formats
  5. Labeling Techniques
  6. Amplification Methods
C. Detection Technologies
  1. Radioactive Methods
    a. Overview
    b. Major Isotopes
      P  32
      S  35
      H  3
      I  125
  2. Non  Isotopic Methods
    a. Enzymatic Labels
    b. Chemical Labeling
      Indirect Chemical Labeling
      Direct Chemical Labeling
    c. Fluorescence
    d. Chemiluminescence
    e. Electrical Conductivity
D. Molecular Diagnostic Instrumentation Review
  1. Abbott LCx
  2. Beckman Coulter/Biomek FK
  3. BD Viper System with XTR Technology
  4. BD Innova
  5. Becton Dickinson SDA
  6. bioMerieux NucliSENS easyMAG
  7. bioMerieux NucliSENS easyQ and MiniMAG
  8. Bio  Rad GeneScope
  9. Cepheid GeneXpert
  10. CURETIS UNYVERO

  11. GENMARK DX ESENSOR XT  8

  12. HOLOGIC/GEN  PROBE PANTHER

  13. HOLOGIC/GEN  PROBE TIGRIS/DTS

  14. HTG MOLECULAR EDGE

  15. LIFE TECHNOLOGIES QUANTSTUDI      DX

  16. QIAGEN QIASYMPHONY RGQ

  17. Roche Cobas Amplicor
  18. ROCHE COBAS TAQMAN

  19. ROCHE COBAS TAQMAN

  0. ROCHE COBAS TAQMAN AMPLIPREP

  1. ROCHE LIGHCYCLER

  2. ROCHE COBAS 4800

  3. ROCHE COBAS S

  4. SIEMENS VERSANT

  25. Tecan LS Series
E. Biochips: Genosensors, Microarrays, and Labs  on  the  Chip
Liquid Transportation and Mixing
Separation
Reaction
Detection
F. Pharmacogenomics
G. Major Applications
  1. Microbiology/Infectious Diseases
    a. Overview
    b. Major Infectious Diseases
  AIDS: HIV/HIV  1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV  I/II
  Adenovirus
  Aeromonas
  Anthrax/Bacillus Anthracis
  Arboviruses
  Babesiosis
  Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
  Blastocystis Hominis
  Brucella
  Campylobacter
  Candida
  Chagas Disease
  Chancroid
  Chlamydia
  Clostridium Difficile
  Coronaviruses
  Coxsackieviruses
  Creutzfeldt  Jakob’s Disease
  Cryptosporidium Parvum
  Cyclospora Cayetanensis
  Cytomegalovirus
  Ebola Virus
  E. Coli
  EchoVirus
  Encephalitis
  Enteroviruses
  Epstein  Barr Virus
  Giardia Lamblia
  Gonorrhea
  Granuloma Inguinale
  Hantavirus
  Helicobacter Pylori
  Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti  HBc, Anti  HBs, Anti  HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
  Herpes Simplex Virus
  Human Herpes Virus  6 (HHV  6)
  Influenza Viruses
  Legionella
  Lyme Disease
  Lymphogranuloma Venereum (LGV)
  Malaria
  Measles (Rubeola)
  Meningitis
  Microsporidium
  Mononucleosis
  Mumps
  Mycoplasma
  Papillomaviruses
  Parvovirus B19
  Pneumonia
  Polyomaviruses
  Pseudomonas Aeruginosa
  Rabies
  Respiratory Syncytial Virus (RSV)
  Rhinoviruses
  Rotavirus
  Rubella
  Salmonellosis
  Septicemia
  Shigellosis
  Staphylococcus Aureus
  Streptococci
  Syphilis
  Toxoplasmosis
  Trichomonas Vaginalis
  Tuberculosis
  Vibrio
  West Nile Virus
  Yersina
  2. Cancer Testing
    a. Overview
    b. Major Cancer Types
    Prostate
    Lung
    Colon and Rectum
    Breast
    Skin
    Uterine
    Leukemia
    Oral
    c. Oncogenes
      Abl/abl  bcr
      AIB1

      BCL  2
      BRCA1

      CD44

      C  fos
      C  myb
      C  myc
      CYP17

      Erb  B
      HPC1

      N  myc
      P40

      P51

      P53
      PIK3CA

      PTI  1

      Ras
      Reg
      Sis
      Src
  3. Genetic Diseases
    a. Overview
    b. Nucleic Acid Amplification
    c. Chromosome Imaging
    d. Genomics Technologies
    e. Proteomics Technologies
f. Current Pharmacogenomic Tests
g. Future Pharmacogenomic Testing
h. Major Diseases
    Achondroplasia
    Autosomal Dominant Polycystic Kidney
Disease
    Cancer
    Cosmetogenomics
    Cystic Fibrosis
    Down's Syndrome
    Duchenne and Becker Muscular Dystrophy
    Factor V (Leiden)
    Factor IX Deficiency
    Fragile X Syndrome
    Heart Disease
    Hemochomatosis
    Hemophilia
    Huntington's Disease
    Maternal  Fetal Incompatibility
    Multiple Endocrine Neoplasia
    Phenylketonuria (PKU)
    Polycystic Kidney Disease (PKD)
    Prenatal Screening
    Retinitis Pigmentosa
    Retinoblastoma
    Sickle Cell Anemia
    Spinal Muscular Atrophy
    Vitamin B12 Metabolism
i. Social Issues and Concerns
  4. Forensic Testing
    a. Overview
    b. Multilocus and Single Locus Probes
    Multilocus Probes
    Single Locus Probes
    PCR and RFLP
    c. The FBI
    d. DNA Profile Data Banks
    U.S.A.

    U.K.

    e. Judicial Implementation
f. Major Crime Categories
g. Factors Contributing to the DNA Probe
Market Expansion
    Technology Availability
    Use of Hair as Evidence
h. Wildlife Forensics
  5. Paternity Testing/HLA Typing
  6. Other Applications
    a. Disease Susceptibility Testing
    b. Cardiovascular Diseases
    c. Diabetes
    d. Alzheimer's Disease
    e. Periodontal Disease
f. Plasma Purification
g. Organ Transplantation
h. Water Contamination
i. Other
H. Competing/complementing
  1. Monoclonal Antibodies/Immunoassays
  2. RNA Probes
  3. Two  Dimensional Electrophoresis
  4. Flow Cytometry
VII. France Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

VIII. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio  Rad
Biotest
Cepheid
CellMark Forensics/LabCorp
Decode Genetics
Diadexus
Eiken
Elitech Group
Enzo
Exact Sciences
Fujirebio
Grifols
Hologic/Gen  Probe
Illumina
Kreatech/Leica
Li  Cor Biosciences
Monogram Biosciences/LabCorp
Myriad Genetics
Ortho  Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher
XIII. Appendix: Major Universities and Research Centers Developing Molecular Diagnostic Technologies

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases
France Molecular Diagnostics Test Volume And Sales By Major Application  2014  2019
France Laboratories Performing DNA Sequencing By Market Segment  2014
France Molecular Diagnostics Market Potential Laboratory Universe by Market Segment  2014
France Molecular Diagnostics Test Volume By Major Application  2014  2019
France Major Infectious Disease Test Volume by Assay  2014  2019
France Major Infectious Disease Test Volume by Method  2014
France Molecular Diagnostics Market By Major Application  2014  2019
France Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers  2014
France Major Infectious Disease Diagnostics Market by Assay  2014  2019
France AIDS Testing Market Estimated Sales by Major Supplier  2014
France Adenovirus Testing Market Estimated Sales by Major Supplier
France Chlamydia Testing Market Estimated Sales by Major Supplier
France CMV Testing Market Estimated Sales by Major Supplier
France Gonorrhea Testing Market Estimated Sales by Major Supplier
France Hepatitis Testing Market Estimated Sales by Major Supplier
France Hepatitis C Testing Market Estimated Sales by Major Supplier
France HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
France Herpes Testing Market Estimated Sales by Major Supplier
France Influenza Testing Market Estimated Sales by Major Supplier
France Meningitis Testing Market Estimated Sales by Major Supplier
France Mycoplasma Testing Market Estimated Sales by Major Supplier
France RSV Testing Market Estimated Sales by Major Supplier
France Shigella Testing Market Estimated Sales by Major Supplie